Press "Enter" to skip to content

Global Biobank Study Finds New Genetic Loci Linked to Endometriosis

Researchers collaborating through the Global Biobank Meta‑analysis Initiative have released the most extensive genome‑wide association study (GWAS) of endometriosis to date. Analyzing data from more than one million participants—about one‑third of whom are of non‑European ancestry—the study identified 58 genomic regions associated with the condition, including 27 that have not been reported before. The findings broaden understanding of the disease’s genetic architecture and point to new avenues for treatment.

Large, diverse biobank cohort enables new genetic insights

The analysis combined summary statistics from 14 biobanks worldwide, encompassing over 1.06 million women for the broadest case definition (labelled “W”). This group included 50,265 women diagnosed with endometriosis, representing 31.9 % non‑European ancestry. A narrower phenotype that excluded adenomyosis (Wex) comprised 615,050 women and 12,262 cases. Additional, more stringent case definitions based on procedure‑confirmed or surgically confirmed diagnoses yielded smaller sample sets but provided validation for the broader phenotypes.

Case prevalence differed markedly across ancestry groups and phenotyping strategies. For example, the East Asian (EAS) cohort showed a 0.2 % case rate under the procedure‑confirmed narrow definition, whereas the African (AFR) cohort reached 26.20 % under the surgically confirmed narrow definition. European (EUR) participants exhibited a higher proportion of cases than other ancestries for the broad phenotypes, yet a lower proportion for the most stringent definitions. Procedure or surgical confirmation among control participants was relatively consistent across groups (15–17 % procedure, 2–4 % surgical), except for East Asians, where procedure confirmation was only 1.76 %.

Genetic discoveries expand known loci and highlight ancestry‑specific signals

The meta‑analysis across eleven GWAS runs (six multi‑ancestry phenotypes and five single‑ancestry runs) uncovered 3,342 unique genome‑wide significant variants (p < 5 × 10⁻⁸), amounting to 5,332 variant‑phenotype associations. These results replicated 65 of 177 variants listed in the GWAS Catalog and reproduced a majority of signals reported in five prior large endometriosis GWAS.

Significant variants clustered into 249 linkage‑disequilibrium (LD) blocks, which were merged into 108 distinct loci. Conditional analyses revealed 143 independent signals, with eight loci harboring more than one signal—most notably the SYNE1 region, which showed 25 independent signals in the European analysis and 11 in the multi‑ancestry analysis. Consolidating overlapping signals across analyses produced 58 regions of interest. Of these, 44 were identified in multiple ancestries, while three loci (GRB14, ZNF536, CHD6) appeared specific to Europeans and two (2p13.3, 20q13.2) were unique to Africans.

Heterogeneity assessments indicated that most regions (30) displayed low heterogeneity across ancestries, 17 showed moderate heterogeneity, and two exhibited high heterogeneity—2p13.3 (I² = 60 %) and SYNE1 (I² = 79 %). Four loci (DNM3, 2q35, LOC730338, CCDC53) demonstrated non‑overlapping effect‑size confidence intervals between ancestries, underscoring potential population‑specific genetic influences.

Implications for disease mechanisms and potential therapies

Liability‑scale SNP heritability estimates varied modestly by ancestry: 0.133 (SE 0.054) for Africans, 0.106 (SE 0.021) for East Asians, and 0.108 (SE 0.008) for Europeans. Partitioned LD‑score regression linked a substantial share of heritability to enhancers active in uterine tissue—26‑fold enrichment in East Asians and 15‑fold in Europeans—highlighting tissue‑specific regulatory elements as key contributors.

Integrating the GWAS results with multi‑omic datasets, including gene‑expression and Mendelian randomization analyses, implicated a total of 314 genes in endometriosis pathology. The breadth of implicated pathways, spanning inflammation, vascular function, and cellular adhesion, suggests multiple potential therapeutic targets and may inform future biomarker development.

Overall, the study demonstrates the power of large, ancestrally diverse biobank resources to uncover novel genetic risk factors for complex diseases. By revealing both shared and ancestry‑specific loci, the research offers a more comprehensive view of endometriosis genetics and lays groundwork for precision‑medicine approaches aimed at reducing the disease’s substantial pain and fertility burdens.